Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sirolimus 1mg tablets
0802020U0AAADAD
|
Sirolimus | Sirolimus | Malignant Disease and Immunosuppression | 745 |
|
Champix 0.5mg/1mg 4 week treatment initiation pack
0410020C0BBADAC
|
Champix | Varenicline tartrate | Central Nervous System | 744 |
|
Durafiber Ag dressing 10cm x 10cm square
20031700185
|
Durafiber Ag dressing 10cm x 10cm square | Wound Management & Other Dressings | Dressings | 744 |
|
Ondansetron 4mg/2ml solution for injection ampoules
0406000S0AAAAAA
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 744 |
|
Betaxolol 0.25% eye drops
1106000I0AAABAB
|
Betaxolol | Betaxolol | Eye | 743 |
|
Hi-Slip Plus hydrophilic catheter male 8CH-24Ch
21020001310
|
Hi-Slip Plus hydrophilic catheter male 8CH-24Ch | Catheters | Appliances | 743 |
|
Liberty leg bag sleeve large
22800958003
|
Liberty leg bag sleeve large | Tubing And Accessories | Incontinence Appliances | 743 |
|
Saizen 12mg/1.5ml solution for injection cartridges
0605010S0BCAFBR
|
Saizen | Somatropin | Endocrine System | 743 |
|
Sevikar HCT 20mg/5mg/12.5mg tablets
0205052ACBBAAAA
|
Sevikar HCT | Olmesartan medoxomil/amlodipine/hydrochlorothiazide | Cardiovascular System | 743 |
|
Losec MUPS 40mg gastro-resistant tablets
0103050P0BBAFAP
|
Losec | Omeprazole | Gastro-Intestinal System | 742 |
|
Minims pilocarpine nitrate 2% eye drops 0.5ml unit dose
1106000Y0BBACAB
|
Minims pilocarpine nitrate | Pilocarpine nitrate | Eye | 742 |
|
Ropinirole 3mg modified-release tablets
0409010H0AAARAR
|
Ropinirole hydrochloride | Ropinirole hydrochloride | Central Nervous System | 742 |
|
Scandonest plain 3% solution for injection 2.2ml cartridges
1502010ABBBABAB
|
Scandonest | Mepivacaine hydrochloride | Anaesthesia | 742 |
|
Affenid XL 18mg tablets
0404000M0BMAAAM
|
Affenid | Methylphenidate hydrochloride | Central Nervous System | 741 |
|
HumaPen Savvio hypod insulin inj pen reusable for 3ml cart 1 unit dial up / range 1-60 units red
21010900798
|
HumaPen Savvio hypod insulin inj pen reusable for 3ml cart 1 unit dial up / range 1-60 units red | Other Appliances | Appliances | 740 |
|
Aloflute 25micrograms/dose / 125micrograms/dose inhaler
0302000N0BJAABF
|
Aloflute | Fluticasone propionate (Inhalation) | Respiratory System | 739 |
|
Azathioprine 75mg tablets
0802010G0AACMCM
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 739 |
|
Lipantil Micro 267 capsules
0212000P0BBADAD
|
Lipantil | Fenofibrate | Cardiovascular System | 739 |
|
DEKAs Essential capsules
0913282B0BBAAAA
|
DEKAs tablets/capsules micronutrient supplement | Tablets/capsules micronutrient supplement (0913282) | Nutrition and Blood | 738 |
|
Erythromycin ethyl succinate 500mg/5ml oral suspension
0501050H0AAACAC
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 738 |
|
Imodium Classic 2mg capsules
0104020L0BBAHAA
|
Imodium | Loperamide hydrochloride | Gastro-Intestinal System | 738 |
|
Maalox 175mg/200mg/5ml oral suspension
0101010G0BBAHAG
|
Maalox | Co-magaldrox (Magnesium/aluminium hydroxide) | Gastro-Intestinal System | 738 |
|
SenSura Mio Click two piece ostomy system ileostomy bag with filter, maxi 60mm grey
23941010008
|
SenSura Mio Click two piece ostomy system ileostomy bag with filter, maxi 60mm grey | Two Piece Ostomy Systems | Stoma Appliances | 738 |
|
SenSura Mio soft convex ileostomy bag with filter, maxi 25mm neutral grey
23601006363
|
SenSura Mio soft convex ileostomy bag with filter, maxi 25mm neutral grey | Ileostomy Bags | Stoma Appliances | 738 |
|
SunVit-D3 10,000unit capsules
0906040G0BWAPDV
|
SunVit-D3 | Colecalciferol | Nutrition and Blood | 738 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.